AUDION THERAPEUTICS
Audion Therapeutics BV, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases affecting the ear, including hearing loss. The companyโs hearing loss small molecule drug discovery program focuses on inner hair cell regeneration. Its IP portfolio includes new molecules, delivery systems, and drug discovery tools for hearing and hearing loss research. The company was founded in 2008 and is based in Amsterdam, the Netherlands.
AUDION THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science Medical Device
Founded:
2008-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.audiontherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+31646767255
Total Funding:
5.8 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API WordPress Font Awesome Organization Schema Contact Form 7 GStatic Google Static Content WPForms
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Vector Bioscience Cambridge
Vector Bioscience Cambridge is a spin-out company from the University of Cambridge that facilitates macromolecule delivery.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.audiontherapeutics.com
- Host name: 166.0.153.160.host.secureserver.net
- IP address: 160.153.0.166
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Audion Therapeutics"
About Audion - Audion Therapeutics
About Audion Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss. Our lead program is aimed at regenerating cells and neuronal โฆSee details»
Hearing Loss - Audion Therapeutics
Hearing Loss Hearing loss affects hundreds of millions people worldwide. The World Health Organization estimates that 500 million people worldwide have a mild to moderate to severe or greater hearing loss. While the prevalence of โฆSee details»
Audion Therapeutics - LinkedIn
Audion Therapeutics | 319 followers on LinkedIn. Leading, clinical stage company developing small molecule regenerative treatment for acquired sensorineural hearing loss | Audion โฆSee details»
Audion Therapeutics - Crunchbase Company Profile & Funding
Audion Therapeutics BV, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs and delivery technologies for the treatment of diseases โฆSee details»
Drug pipelines, Patents, Clinical trials - Synapse - Patsnap
Explore Audion Therapeutics BV with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Disease Domain:Nervous System Diseases, Technology Platform:Small โฆSee details»
Audion Therapeutics - Craft
Audion Therapeutics is a biopharmaceutical company that discovers, develops, and commercializes treatments for hearing loss. It offers IP portfolio that encompasses molecules, โฆSee details»
Audion Therapeutics - Overview, News & Competitors - ZoomInfo
Audion Therapeutics - Business Information. Manufacturing · Netherlands · <25 Employees. About Audion Therapeutics Audion Therapeutics BV is a private pharmaceutical company โฆSee details»
Audion Therapeutics Overview | SignalHire Company Profile
Audion Therapeutics is a private biopharmaceutical company dedicated to the discovery and development of drugs for the treatment of acquired hearing loss. Audionโs headquarters are in โฆSee details»
Investors - Audion Therapeutics
Investors Audion is supported by investors that share our motivation to advance treatments for people with hearing loss.See details»
Audion Therapeutics - VentureRadar
Audion Therapeutics discovers, develops and commercializes new treatments for hearing loss. ... Find out more about Audion Therapeutics, Small Molecule Pharmaceuticals, Life Sciences and โฆSee details»
Audiontherapeutics.com - Customer Reviews - Webwiki
According to the recently updated World Health Organization estimates, 1 in 4 people worldwide. Reviews and ratings of Audiontherapeutics.com. ... Audion, Hearing Loss and Management โฆSee details»
Audion Therapeutics - PitchBook
Audion Therapeutics General Information Description. Operator of a clinical-stage company intended to develop therapies to treat hearing loss. The company is involved in the discovery โฆSee details»
Audion therapeutics Reviews | Read Client Reviews of Audion โฆ
Read reviews of Audion therapeutics. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Contact - Audion Therapeutics
Contact General Information, Press & Job Requests If you are a media representative or a medical professional and would like to learn more about the Audion programs, you can contact โฆSee details»
Pharma companies team up to develop drugs for hearing loss
Jun 21, 2011 The World Health Organization estimates that 500 million people worldwide have a mild to moderate to severe or greater hearing loss. Of people aged 65 to 74, nearly 33% have โฆSee details»
Audion Therapeutics - VentureRadar
Similar Companies: Decibel Therapeutics USA Publicly Traded Decibel Therapeutics has established the world's first comprehensive drug discovery, development, and translational โฆSee details»
Development - Audion Therapeutics
Development Advanced Development Audionโs lead program has undergone a thorough and extensive preclinical characterization in multiple model systems prior to initiation of the clinical โฆSee details»
Audion Therapeutics | Tinnitus Talk Support Forum
May 2, 2014 Here is another company working on hearing loss and cell regeneration. I think this is the one that discovered that Notch inhibition transforms subcells into haircells.See details»
Our Science - Audion Therapeutics
Our Science Audionโs lead program, a small molecule gamma secretase inhibitor AUD1001, is in clinical development for acquired hearing loss. Pioneering Science Sensorineural hearing loss โฆSee details»